Rayovac 2001 Annual Report Download - page 4

Download and view the complete annual report

Please find page 4 of the 2001 Rayovac annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 21

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21

1997 1998 1999 2000 2001
Total revenue $427.2 $487.4 $555.1 $693.3 $675.5
Adjusted gross profit1192.2 229.1 261.2 335.1 329.5
Adjusted operating income137.5 46.7 63.0 89.3 76.7
Adjusted EBITDA148.5 59.2 76.8 108.6 96.8
Net income 6.2 14.4 24.1 38.4 11.5
Adjusted net income19.2 21.4 30.4 38.4 31.1
Diluted net income per common share $ 0.30 $ 0.51 $ 0.83 $ 1.32 $ 0.39
Adjusted diluted net income per common share2$ 0.45 $ 0.74 $ 1.04 $ 1.32 $ 1.05
1 Adjusted for recapitalization and other special charges. EBITDA represents income from operations
plus other (income) expense, net plus depreciation and amortization (excluding amortization of debt issuance costs).
2 Adjusted for recapitalization, interest expense as if the IPO had taken place October 1, 1997, other special charges, and extraordinary items.
•Secured major distribution gains with Toys “R” Us, The Home Depot
and Lowe’s in the U.S.; Ahold, Makro and Jumbo in Latin America; and
Kingfisher in Europe
•Completed a global restructuring that will generate more than $12 million
in annual savings
•Executed a 3.5 million share stock offering that improved liquidity and
retired $65 million of debt
•Increased our adjusted gross profit margin by 50 basis points
•Introduced the world’s first one-hour charger for high-capacity, 1600 mAh,
rechargeable Nickel Metal Hydride (NiMH) batteries
•Developed a new zinc air battery that combines long life and unprecedented
power for hearing aids used by the severely hearing impaired
Fiscal 2001 Highlights
Financial and Operating Highlights
In millions, except per share amounts.
1
Rayovac 2001